216 related articles for article (PubMed ID: 28264934)
1. Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca
Chen J; De Raeymaecker J; Hovgaard JB; Smaardijk S; Vandecaetsbeek I; Wuytack F; Møller JV; Eggermont J; De Maeyer M; Christensen SB; Vangheluwe P
J Biol Chem; 2017 Apr; 292(17):6938-6951. PubMed ID: 28264934
[TBL] [Abstract][Full Text] [Related]
2. An N-terminal Ca
Chen J; Smaardijk S; Mattelaer CA; Pamula F; Vandecaetsbeek I; Vanoevelen J; Wuytack F; Lescrinier E; Eggermont J; Vangheluwe P
J Biol Chem; 2019 May; 294(19):7878-7891. PubMed ID: 30923126
[TBL] [Abstract][Full Text] [Related]
3. Thapsigargin affinity purification of intracellular P(2A)-type Ca(2+) ATPases.
Vandecaetsbeek I; Christensen SB; Liu H; Van Veldhoven PP; Waelkens E; Eggermont J; Raeymaekers L; Møller JV; Nissen P; Wuytack F; Vangheluwe P
Biochim Biophys Acta; 2011 May; 1813(5):1118-27. PubMed ID: 21215281
[TBL] [Abstract][Full Text] [Related]
4. Effects of high-affinity inhibitors on partial reactions, charge movements, and conformational States of the Ca2+ transport ATPase (sarco-endoplasmic reticulum Ca2+ ATPase).
Tadini-Buoninsegni F; Bartolommei G; Moncelli MR; Tal DM; Lewis D; Inesi G
Mol Pharmacol; 2008 Apr; 73(4):1134-40. PubMed ID: 18212248
[TBL] [Abstract][Full Text] [Related]
5. Functional comparison between secretory pathway Ca2+/Mn2+-ATPase (SPCA) 1 and sarcoplasmic reticulum Ca2+-ATPase (SERCA) 1 isoforms by steady-state and transient kinetic analyses.
Dode L; Andersen JP; Raeymaekers L; Missiaen L; Vilsen B; Wuytack F
J Biol Chem; 2005 Nov; 280(47):39124-34. PubMed ID: 16192278
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel inhibitors of human SPCA2.
Yamamoto S; Takehara M; Kabashima Y; Fukutomi T; Ushimaru M
Biochem Biophys Res Commun; 2016 Aug; 477(2):266-70. PubMed ID: 27297103
[TBL] [Abstract][Full Text] [Related]
7. Critical roles of hydrophobicity and orientation of side chains for inactivation of sarcoplasmic reticulum Ca2+-ATPase with thapsigargin and thapsigargin analogs.
Winther AM; Liu H; Sonntag Y; Olesen C; le Maire M; Soehoel H; Olsen CE; Christensen SB; Nissen P; Møller JV
J Biol Chem; 2010 Sep; 285(37):28883-92. PubMed ID: 20551329
[TBL] [Abstract][Full Text] [Related]
8. Applying linear interaction energy method for rational design of noncompetitive allosteric inhibitors of the sarco- and endoplasmic reticulum calcium-ATPase.
Singh P; Mhaka AM; Christensen SB; Gray JJ; Denmeade SR; Isaacs JT
J Med Chem; 2005 Apr; 48(8):3005-14. PubMed ID: 15828839
[TBL] [Abstract][Full Text] [Related]
9. Specific structural requirements for the inhibitory effect of thapsigargin on the Ca2+ ATPase SERCA.
Xu C; Ma H; Inesi G; Al-Shawi MK; Toyoshima C
J Biol Chem; 2004 Apr; 279(17):17973-9. PubMed ID: 14970206
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of the topography of the thapsigargin binding site in the sarco-endoplasmic calcium ATPase.
Skytte DM; Møller JV; Liu H; Nielsen HØ; Svenningsen LE; Jensen CM; Olsen CE; Christensen SB
Bioorg Med Chem; 2010 Aug; 18(15):5634-46. PubMed ID: 20615710
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the sarco/endoplasmic reticulum (ER) Ca
Sehgal P; Szalai P; Olesen C; Praetorius HA; Nissen P; Christensen SB; Engedal N; Møller JV
J Biol Chem; 2017 Dec; 292(48):19656-19673. PubMed ID: 28972171
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of thapsigargin binding by SERCA Ca2+-ATPase: a computational docking study.
Paula S; Ball WJ
Proteins; 2004 Aug; 56(3):595-606. PubMed ID: 15229891
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ uptake and release properties of a thapsigargin-insensitive nonmitochondrial Ca2+ store in A7r5 and 16HBE14o- cells.
Missiaen L; Vanoevelen J; Parys JB; Raeymaekers L; De Smedt H; Callewaert G; Erneux C; Wuytack F
J Biol Chem; 2002 Mar; 277(9):6898-902. PubMed ID: 11861657
[TBL] [Abstract][Full Text] [Related]
14. Identifying the sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) as a potential target for hypericin--a theoretical study.
Eriksson ES; Eriksson LA
Phys Chem Chem Phys; 2012 Sep; 14(36):12637-46. PubMed ID: 22892582
[TBL] [Abstract][Full Text] [Related]
15. Cryo-EM structures of human SPCA1a reveal the mechanism of Ca
Chen Z; Watanabe S; Hashida H; Inoue M; Daigaku Y; Kikkawa M; Inaba K
Sci Adv; 2023 Mar; 9(9):eadd9742. PubMed ID: 36867705
[TBL] [Abstract][Full Text] [Related]
16. A Darier disease mutation relieves kinetic constraints imposed by the tail of sarco(endo)plasmic reticulum Ca
Mikkelsen SA; Vangheluwe P; Andersen JP
J Biol Chem; 2018 Mar; 293(11):3880-3889. PubMed ID: 29363575
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells.
Jakobsen CM; Denmeade SR; Isaacs JT; Gady A; Olsen CE; Christensen SB
J Med Chem; 2001 Dec; 44(26):4696-703. PubMed ID: 11741487
[TBL] [Abstract][Full Text] [Related]
18. Comparison of current docking tools for the simulation of inhibitor binding by the transmembrane domain of the sarco/endoplasmic reticulum calcium ATPase.
Lape M; Elam C; Paula S
Biophys Chem; 2010 Aug; 150(1-3):88-97. PubMed ID: 20167416
[TBL] [Abstract][Full Text] [Related]
19. Overlapping effects of S3 stalk segment mutations on the affinity of Ca2+-ATPase (SERCA) for thapsigargin and cyclopiazonic acid.
Ma H; Zhong L; Inesi G; Fortea I; Soler F; Fernandez-Belda F
Biochemistry; 1999 Nov; 38(47):15522-7. PubMed ID: 10569935
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of the Ca
Maréchal X; De Mendonça R; Miras R; Revilloud J; Catty P
Biochem J; 2018 Jan; 475(1):289-303. PubMed ID: 29229760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
